Net profit of Syncom Formulations (India) declined 12.63% to Rs 7.40 crore in the quarter ended March 2024 as against Rs 8.47 crore during the previous quarter ended March 2023. Sales rose 22.29% to Rs 74.57 crore in the quarter ended March 2024 as against Rs 60.98 crore during the previous quarter ended March 2023.
For the full year,net profit rose 26.11% to Rs 25.31 crore in the year ended March 2024 as against Rs 20.07 crore during the previous year ended March 2023. Sales rose 17.45% to Rs 263.39 crore in the year ended March 2024 as against Rs 224.25 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 74.57 | 60.98 | 22 | 263.39 | 224.25 | 17 |
| OPM % | 12.63 | 9.77 | - | 11.25 | 8.75 | - |
| PBDT | 11.33 | 11.44 | -1 | 38.70 | 31.10 | 24 |
| PBT | 10.03 | 10.27 | -2 | 33.97 | 26.56 | 28 |
| NP | 7.40 | 8.47 | -13 | 25.31 | 20.07 | 26 |